Detailed price information for Phathom Pharmaceuticals Inc (PHAT-Q) from The Globe and Mail including charting and trades.
Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...
Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.
Baystreet.ca News Commentary – Longevity science advances reveal how genes from supercentenarians can reverse cardiac aging[1 ...
For more than half a century, Johns Hopkins has been a leader in converting federal support into tangible benefits for the ...
THE colder, darker months can quietly wreak havoc on our skin – and our lifespans. Wrinkles become deeper, dryness sets in, ...
Discover how CoQ10 fuels your body’s energy systems, protects against oxidative damage, and supports heart and metabolic ...
FOCUS is a randomized, double-blind, placebo-controlled crossover pilot study evaluating Tonix's investigational intranasal potentiated oxytocin products in patients with Arginine-Vasopressin Deficien ...
Q3 2025 Earnings Call October 24, 2025 8:30 AM EDTCompany ParticipantsThomas Larsen - Head of Investor RelationsPaul Hudson - CEO ...
Ooops... Something went wrong while loading this page.
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced positive results from the pivotal Phase 3 EV-303 clinical trial (also known as ...
3don MSN
Myth versus fact: What we know about the risks and side effects of the new weight-loss drugs
Pancreatitis, vision loss ... the risks of drugs such as Ozempic can sound scary. But what does the evidence show?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback